Cover Image

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Chen, Jie, Gruber, Susan, Lee, Hana, Chu, Haitao, Lee, Shiowjen, Tian, Haijun, Wang, Yan, He, Weili, Jemielita, Thomas, Song, Yang, Tamura, Roy, Tian, Lu, Zhao, Yihua, Chen, Yong, van der Laan, Mark, Nie, Lei
Format:	Preprint
Published:	2024
Subjects:	Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
by: Jie Chen, et al.
Published: (2025)

Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
by: Jie Chen, et al.
Published: (2025)

Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
by: Chen, Jie, et al.
Published: (2024)

Sensitivity Analysis for Unmeasured Confounding in Medical Product Development and Evaluation Using Real World Evidence
by: Fang, Yixin, et al.
Published: (2023)

Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
by: Chen, Jie, et al.
Published: (2024)

Decentralized Clinical Trials in the Era of Real‐World Evidence: A Statistical Perspective
by: Jie Chen, et al.
Published: (2025)

A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints
by: Zhou, Tianyue, et al.
Published: (2026)

Practical considerations for specifying a super learner
by: Phillips, Rachael V., et al.
Published: (2022)

Adaptive-TMLE for the Average Treatment Effect based on Randomized Controlled Trial Augmented with Real-World Data
by: van der Laan, Mark, et al.
Published: (2024)

Decentralized Clinical Trials in the Era of Real‐World Evidence: A Critical Assessment of Recent Experiences
by: Hongwei Wang, et al.
Published: (2025)

Technical Note: Targeted Maximum Likelihood Estimator for an ATE Standardized for New Target Population
by: van der Laan, Mark, et al.
Published: (2025)

The Use of Real‐World Evidence for Regulatory Decisions in China
by: Jiayue Xu, et al.
Published: (2024)

Drugs - Real World Outcomes
Published: (2016)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
by: Qiu, Sky, et al.
Published: (2026)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
by: Qiu, Sky, et al.
Published: (2025)

Real-World Research: A Qualitative Study of Faculty Perceptions of the Library's Role in Service-Learning
by: Gruber, Anne Marie
Published: (2018)

Balancing Reassurance and Vigilance: Real‐World Evidence in Post‐Marketing Drug Safety
by: Yow‐Ming C. Wang, et al.
Published: (2026)

Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
by: Christine Bangert, et al.
Published: (2025)

Full-Duplex-Bench-v3: Benchmarking Tool Use for Full-Duplex Voice Agents Under Real-World Disfluency
by: Lin, Guan-Ting, et al.
Published: (2026)

ISP-AD: A Large-Scale Real-World Dataset for Advancing Industrial Anomaly Detection with Synthetic and Real Defects
by: Krassnig, Paul J., et al.
Published: (2025)

Bibliographic Instruction for "Real World" Reading.
by: Chin, Susan Ho, et al.
Published: (1989)

Investigating Targeting Strategies and Truncation in TMLE for the Average Treatment Effect under Practical Positivity Violations
by: Xu, Yichen, et al.
Published: (2026)

Can LLM Agents Generate Real-World Evidence? Evaluating Observational Studies in Medical Databases
by: Li, Dubai, et al.
Published: (2026)

US Food and Drug Administration's Advancing Real‐World Evidence Program: Initial Experience
by: Kimberly A. Smith, et al.
Published: (2025)

Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
by: Hwi Seung Kim, et al.
Published: (2025)

Exploring In-Image Machine Translation with Real-World Background
by: Tian, Yanzhi, et al.
Published: (2025)

Gender Differences in Adverse Events of Ketamine Drugs: A Real‐World Study Based on FAERS
by: Jun Zhang, et al.
Published: (2024)

Statistical Reinforcement Learning in the Real World: A Survey of Challenges and Future Directions
by: Gazi, Asim H., et al.
Published: (2026)

Risk of Periodontitis in People With Atopic Dermatitis: Real‐World Evidences
by: Shih‐Chi Yang, et al.
Published: (2025)

Grounding World Simulation Models in a Real-World Metropolis
by: Seo, Junyoung, et al.
Published: (2026)

SWE-Next: Scalable Real-World Software Engineering Tasks for Agents
by: Liang, Jiarong, et al.
Published: (2026)

A Hybrid Quantum Computing Pipeline for Real World Drug Discovery
by: Li, Weitang, et al.
Published: (2024)

Noisy Ostracods: A Fine-Grained, Imbalanced Real-World Dataset for Benchmarking Robust Machine Learning and Label Correction Methods
by: Hu, Jiamian, et al.
Published: (2024)

Association Between Gastroesophageal Reflux Disease and Laryngeal Disorders: Real‐World Evidence
by: I‐Yun Lee, et al.
Published: (2024)

Foundation Models to Unlock Real-World Evidence from Nationwide Medical Claims
by: Ma, Fan, et al.
Published: (2026)

TravelPlanner: A Benchmark for Real-World Planning with Language Agents
by: Xie, Jian, et al.
Published: (2024)

Virtualizing a Collaboration Task as an Interactable Environment and Installing it on Real World
by: Jung, Euijun, et al.
Published: (2025)

Reality Proxy: Fluid Interactions with Real-World Objects in MR via Abstract Representations
by: Liu, Xiaoan, et al.
Published: (2025)

Are Multimodal LLMs Ready for Clinical Dermatology? A Real-World Evaluation in Dermatology
by: Jiang, Roy, et al.
Published: (2026)

Trustworthy AI/ML Regression and Unbiased Causal Inference for Real-World Data
by: Xu, Yifei, et al.
Published: (2026)